ConductScience.org, home

Paper4355362

Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.

Glueck CJ and 2 others. Pediatrics, 1973. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin. Papers, record 4355362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4355362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.
PubMed
Journal
Pediatrics
PubMed
Year
1973
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
2.74
iCite
Revised in PubMed
2009-11-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Glueck CJC J
2Fallat RR
3Tsang RR

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChylomicronsMajor topic
HepatomegalyMajor topic
HyperlipidemiasMajor topic
LipoproteinsMajor topic
Adolescent
Adult
Arteriosclerosis
Child
Cholesterol, Dietary
Cholestyramine Resin
Diet Therapy
Humans
Lipoproteins, LDL
Tendons
Xanthomatosis

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
24913720Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24913720PubMed
9187532A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.Drug Saf1997https://conductscience.org/library/papers/9187532PubMed
8408697Familial hypercholesterolaemia: pilot study to identify children at risk.J Clin Pathol1993https://conductscience.org/library/papers/8408697PubMed
7449793The effect of oral calcium carbonate administration on serum lipoproteins of children with familial hypercholesterolaemia (type II-A).Eur J Pediatr1980https://conductscience.org/library/papers/7449793PubMed
3566319Hypercholesterolaemia treated by soybean protein diet.Arch Dis Child1987https://conductscience.org/library/papers/3566319PubMed
184909Primary hyperlipoproteinemia in childhood and adolescence: identification and treatment of persons at risk for premature atherosclerosis.Can Med Assoc J1976https://conductscience.org/library/papers/184909PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4355362

GET https://conductscience.org/api/papers/v1/4355362/authors